Muscular Strength in Risk Factors for Cardiovascular Disease and Mortality: A Narrative Review

被引:10
|
作者
Lopez-Jaramillo, Patricio [1 ,2 ]
Lopez-Lopez, Jose P. [1 ,2 ,3 ]
Camila Tole, Maria [1 ]
Cohen, Daniel D. [1 ,2 ]
机构
[1] Univ Santander UDES, Masira Res Inst, Med Sch, Bucaramanga, Colombia
[2] Ctr Integral Prevenc Enfermedades Cardiometab, Floridablanca, Colombia
[3] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Cardiol Unit, Bogota, Colombia
来源
ANATOLIAN JOURNAL OF CARDIOLOGY | 2022年 / 26卷 / 08期
关键词
Muscular strength; hand grip; cardiovascular disease; cardiovascular risk factors; chronic diseases; mortality; hypertension; predictors; prevention; diabetes mellitus; GRIP STRENGTH; METABOLIC SYNDROME; HANDGRIP STRENGTH; BLOOD-PRESSURE; CARDIORESPIRATORY FITNESS; INCIDENT HYPERTENSION; MUSCLE STRENGTH; RESISTANCE; ASSOCIATION; POPULATION;
D O I
10.5152/AnatolJCardiol.2022.1586
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of death globally, accounting for approximately 32% of all deaths in 2019. There has been increasing interest in understanding the role of low muscular strength as a risk factor for cardiovascular disease, given its association with other cardiovascular risk factors such as hypertension, diabetes mellitus, and metabolic syndrome. An inverse association between muscle strength, chronic disease, all-cause mortality, and cardiovascular-related death has been reported. Recent clinical trials have consistently shown that resistance exercise, which increases strength, and potentially muscle mass, significantly improves the control of known cardiovascular disease risk factors and reduces the risk of all-cause death and cardiovascular mortality. In the present article, we review the growing body of evidence that supports the need for future research to evaluate the potential of handgrip strength as a screening tool for cardiovascular disease and its risk factors in the clinical medical setting, as part of routine care using an affordable handgrip strength device. Moreover, it is crucial to devise large-scale interventions driven by governmental health policies to educate the general population and healthcare professionals about the importance of muscular strengthening activities and to promote access to these activities to improve cardiometabolic health and reduce incidence of cardiovascular disease and mortality.
引用
收藏
页码:598 / 607
页数:10
相关论文
共 50 条
  • [21] Cardiovascular risk factors and mortality in children with chronic kidney disease
    Mudi, A.
    Dickens, C.
    Levy, C.
    Ballot, D.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2017, 107 (08): : 710 - 714
  • [22] Cardiovascular Disease Risk Factors and Mortality in Russia: Challenges and Barriers
    Petrukhin, Igor S.
    Lunina, Elena Yu
    [J]. PUBLIC HEALTH REVIEWS, 2011, 33 (02) : 436 - 449
  • [23] Blood pressure components as risk factors for cardiovascular disease mortality
    Bowman, T
    Sesso, H
    Gaziano, M
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 141 - 141
  • [24] Mortality and Associated Risk Factors in Dialysis Patients with Cardiovascular Disease
    Tong, Junrong
    Liu, Manyi
    Li, Hong
    Luo, Zhengmao
    Zhong, Xianyang
    Huang, Jun
    Liu, Riguang
    He, Feng
    Fu, Junzhou
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2016, 41 (04): : 479 - 487
  • [25] Cardiovascular risk factors and mortality in patients with coronary heart disease
    Prugger, Christof
    Wellmann, Jurgen
    Heidrich, Jan
    Brand-Herrmann, Stefan-Martin
    Keil, Ulrich
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2008, 23 (11) : 731 - 737
  • [26] Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
    Magnussen, Christina
    Ojeda, Francisco M.
    Leong, Darryl P.
    Alegre-Diaz, Jesus
    Amouyel, Philippe
    Aviles-Santa, Larissa
    De Bacquer, Dirk
    Ballantyne, Christie M.
    Bernabe-Ortiz, Antonio
    Bobak, Martin
    Brenner, Hermann
    Carrillo-Larco, Rodrigo M.
    de Lemos, James
    Dobson, Annette
    Dorr, Marcus
    Donfrancesco, Chiara
    Drygas, Wojciech
    Dullaart, Robin P.
    Engstrom, Gunnar
    Ferrario, Marco M.
    Ferrieres, Jean
    de Gaetano, Giovanni
    Goldbourt, Uri
    Gonzalez, Clicerio
    Grassi, Guido
    Hodge, Allison M.
    Hveem, Kristian
    Iacoviello, Licia
    Ikram, M. Kamran
    Irazola, Vilma
    Jobe, Modou
    Jousilahti, Pekka
    Kaleebu, Pontiano
    Kavousi, Maryam
    Kee, Frank
    Khalili, Davood
    Koenig, Wolfgang
    Kontsevaya, Anna
    Kuulasmaa, Kari
    Lackner, Karl J.
    Leistner, David M.
    Lind, Lars
    Linneberg, Allan
    Lorenz, Thiess
    Lyngbakken, Magnus Nakrem
    Malekzadeh, Reza
    Malyutina, Sofia
    Mathiesen, Ellisiv B.
    Melander, Olle
    Metspalu, Andres
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (14): : 1273 - 1285
  • [27] Cardiovascular risk factors and mortality in patients with coronary heart disease
    Christof Prugger
    Jürgen Wellmann
    Jan Heidrich
    Stefan-Martin Brand-Herrmann
    Ulrich Keil
    [J]. European Journal of Epidemiology, 2008, 23 : 731 - 737
  • [28] Is Thoracic Aortic Diameter an Independent Predictor of Cardiovascular Disease and Mortality? A Narrative Review
    Tadic, Marijana
    Gherbesi, Elisa
    Sala, Carla
    Carugo, Stefano
    Cuspidi, Cesare
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [29] Review: Statins reduce mortality and cardiovascular events in adults at risk for cardiovascular disease
    Brugts, J. J.
    Yetgin, T.
    Hoeks, S. E.
    Davidson, Richard A.
    Rosenberg, Eric
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 151 (08)
  • [30] Cardiovascular Disease and Risk Factors in Asia A Selected Review
    Ueshima, Hirotsugu
    Sekikawa, Akira
    Miura, Katsuyuki
    Turin, Tanvir Chowdhury
    Takashima, Naoyuki
    Kita, Yoshikuni
    Watanabe, Makoto
    Kadota, Aya
    Okuda, Nagako
    Kadowaki, Takashi
    Nakamura, Yasuyuki
    Okamura, Tomonori
    [J]. CIRCULATION, 2008, 118 (25) : 2702 - 2709